Clinical Study to Monitor Plasma Levels of 24OHC in Subject With HD

Clinical Study to Monitor Plasma Levels of 24OHC in Subject With HD

Publication date: Feb 06, 2020

A 2-year clinical longitudinal study to measure plasma concentrations of 24S-hydroxycholesterol, a brain-derived cholesterol catabolite, in subjects with Huntington disease, from the presymptomatic to the symptomatic stages.

Concepts Keywords
Assay MRI
Biomarker Huntingtin
Blood Clinical medicine
Brain Medicine
Catabolite RTT
Cholesterol Huntington’s disease
Chorea Trinucleotide repeat disorders
Claustrophobia Autosomal dominant disorders
Cognitive Branches of biology
Cross
Gene
Huntington
Intrauterine Devices
Longitudinal Study
Marder
Mario
Mass Spectrometry
MRI
Mutation
Neurological
Pharmacological
Phenotypic
Plasma
Sterols
Subject 2

Semantics

Type Source Name
pathway KEGG Huntington disease
disease MESH claustrophobia
disease MESH chorea
disease MESH Huntington disease
drug DRUGBANK Cholesterol

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *